NO304595B1 - Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av dem - Google Patents
Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av demInfo
- Publication number
- NO304595B1 NO304595B1 NO943837A NO943837A NO304595B1 NO 304595 B1 NO304595 B1 NO 304595B1 NO 943837 A NO943837 A NO 943837A NO 943837 A NO943837 A NO 943837A NO 304595 B1 NO304595 B1 NO 304595B1
- Authority
- NO
- Norway
- Prior art keywords
- naphthylpyrazole
- carboxamides
- intermediates
- preparation
- pharmaceutical preparations
- Prior art date
Links
- PNLLWTUHUQZJRP-UHFFFAOYSA-N 4-naphthalen-1-yl-1h-pyrazole-5-carboxamide Chemical class N1N=CC(C=2C3=CC=CC=C3C=CC=2)=C1C(=O)N PNLLWTUHUQZJRP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
- C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312136A FR2711140B1 (fr) | 1993-10-12 | 1993-10-12 | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO943837D0 NO943837D0 (no) | 1994-10-11 |
| NO943837L NO943837L (no) | 1995-04-18 |
| NO304595B1 true NO304595B1 (no) | 1999-01-18 |
Family
ID=9451754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943837A NO304595B1 (no) | 1993-10-12 | 1994-10-11 | Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av dem |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US5502059A (no) |
| EP (1) | EP0647629B1 (no) |
| JP (1) | JPH07278114A (no) |
| KR (1) | KR950011413A (no) |
| CN (1) | CN1108651A (no) |
| AT (1) | ATE181911T1 (no) |
| AU (1) | AU685154B2 (no) |
| CA (1) | CA2117821A1 (no) |
| DE (1) | DE69419377D1 (no) |
| FI (1) | FI944770A (no) |
| FR (1) | FR2711140B1 (no) |
| HU (1) | HUT70048A (no) |
| IL (1) | IL111239A0 (no) |
| NO (1) | NO304595B1 (no) |
| NZ (1) | NZ264661A (no) |
| RU (1) | RU2140912C1 (no) |
| TW (1) | TW300890B (no) |
| ZA (1) | ZA947957B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716991B1 (en) | 1993-11-30 | 2004-04-06 | G. D. Searle & Co. | Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| US6492411B1 (en) | 1993-11-30 | 2002-12-10 | G. D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| FR2732967B1 (fr) * | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| US6521561B1 (en) * | 1998-05-01 | 2003-02-18 | President And Fellows Of Harvard College | Main-group metal based asymmetric catalysts and applications thereof |
| IL142707A0 (en) * | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| US6814888B2 (en) * | 2001-05-11 | 2004-11-09 | Mitsui Chemicals, Inc. | Dopant agent and electroconductive polymer material comprising the same |
| CA2449451C (en) * | 2001-07-11 | 2009-12-08 | Nathan Yee | A novel synthesis for heteroarylamine compounds |
| US6603000B2 (en) | 2001-07-11 | 2003-08-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Synthesis for heteroarylamine compounds |
| AR038967A1 (es) | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina |
| GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| EP2368881A1 (en) * | 2005-01-10 | 2011-09-28 | University of Connecticut | Heteropyrazole analogs acting on cannabinoid receptors |
| US7714014B2 (en) * | 2005-12-09 | 2010-05-11 | The Regents Of The University Of California | Targeting GLI proteins in human cancer by small molecules |
| EP1988777B1 (en) * | 2006-02-09 | 2011-09-21 | Athersys, Inc. | Pyrazoles for the treatment of obesity and other cns disorders |
| EP2740726A1 (en) * | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| CN106459004B (zh) | 2014-06-06 | 2020-09-15 | 研究三角协会 | 爱帕琳肽受体(apj)激动剂及其用途 |
| AU2016366310C1 (en) | 2015-12-09 | 2021-09-09 | Research Triangle Institute | Improved apelin receptor (APJ) agonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| US5288877A (en) * | 1991-07-03 | 1994-02-22 | Ppg Industries, Inc. | Continuous process for preparing indolenine compounds |
| IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1993
- 1993-10-12 FR FR9312136A patent/FR2711140B1/fr not_active Expired - Fee Related
-
1994
- 1994-10-10 DE DE69419377T patent/DE69419377D1/de not_active Expired - Lifetime
- 1994-10-10 EP EP94402263A patent/EP0647629B1/fr not_active Expired - Lifetime
- 1994-10-10 AT AT94402263T patent/ATE181911T1/de not_active IP Right Cessation
- 1994-10-11 US US08/320,270 patent/US5502059A/en not_active Expired - Fee Related
- 1994-10-11 HU HU9402933A patent/HUT70048A/hu unknown
- 1994-10-11 TW TW083109399A patent/TW300890B/zh active
- 1994-10-11 CA CA002117821A patent/CA2117821A1/en not_active Abandoned
- 1994-10-11 FI FI944770A patent/FI944770A/fi unknown
- 1994-10-11 NO NO943837A patent/NO304595B1/no unknown
- 1994-10-11 RU RU94036749A patent/RU2140912C1/ru active
- 1994-10-11 IL IL11123994A patent/IL111239A0/xx unknown
- 1994-10-12 KR KR1019940026157A patent/KR950011413A/ko not_active Application Discontinuation
- 1994-10-12 AU AU75753/94A patent/AU685154B2/en not_active Ceased
- 1994-10-12 JP JP6246609A patent/JPH07278114A/ja not_active Withdrawn
- 1994-10-12 NZ NZ264661A patent/NZ264661A/en unknown
- 1994-10-12 CN CN94117090A patent/CN1108651A/zh active Pending
- 1994-10-12 ZA ZA947957A patent/ZA947957B/xx unknown
-
1995
- 1995-05-16 US US08/442,106 patent/US5523455A/en not_active Expired - Fee Related
- 1995-05-16 US US08/442,105 patent/US5585497A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI944770A0 (fi) | 1994-10-11 |
| CA2117821A1 (en) | 1995-04-13 |
| AU685154B2 (en) | 1998-01-15 |
| NO943837D0 (no) | 1994-10-11 |
| NO943837L (no) | 1995-04-18 |
| TW300890B (no) | 1997-03-21 |
| HUT70048A (en) | 1995-09-28 |
| CN1108651A (zh) | 1995-09-20 |
| HU9402933D0 (en) | 1995-01-30 |
| FR2711140A1 (fr) | 1995-04-21 |
| US5523455A (en) | 1996-06-04 |
| NZ264661A (en) | 1996-08-27 |
| AU7575394A (en) | 1995-05-04 |
| US5585497A (en) | 1996-12-17 |
| ZA947957B (en) | 1995-05-22 |
| RU2140912C1 (ru) | 1999-11-10 |
| KR950011413A (ko) | 1995-05-15 |
| JPH07278114A (ja) | 1995-10-24 |
| ATE181911T1 (de) | 1999-07-15 |
| US5502059A (en) | 1996-03-26 |
| FI944770A (fi) | 1995-04-13 |
| DE69419377D1 (de) | 1999-08-12 |
| RU94036749A (ru) | 1996-10-10 |
| IL111239A0 (en) | 1994-12-29 |
| EP0647629B1 (fr) | 1999-07-07 |
| EP0647629A1 (fr) | 1995-04-12 |
| FR2711140B1 (fr) | 1996-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO304595B1 (no) | Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, farmas°ytiske preparater inneholdende dem, og mellomprodukter for fremstilling av dem | |
| NO985711D0 (no) | Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler | |
| AU649421B2 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
| BG101118A (en) | Therapeutical compounds | |
| ATE79619T1 (de) | Arzneimittel. | |
| NO995006L (no) | Nye forbindelser | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| IL106842A (en) | Pharmaceutical compositions comprising il-4r or derivatives thereof for the treatment, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and fungal infections | |
| NO890259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| DE69429591T2 (de) | Therapeutisch wirksame Verbindungen | |
| DE69317877T2 (de) | 4''-deoxyerythromycinderivate | |
| NO172537C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater | |
| ZA828639B (en) | Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds | |
| ZA826453B (en) | Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
| NO922635L (no) | Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater | |
| FI883455A0 (fi) | Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter. | |
| NO864475D0 (no) | Cefalosporinderivater og fremgangsmaate til deres fremstilling. | |
| ATE74505T1 (de) | Schmerzpraeparat. | |
| AP9200405A0 (en) | Pharmaceutical formulations comprised of micronised halofantrine. | |
| NO950842L (no) | Diarylpiperazinoacetamidforbindelser som antimuskariniske midler | |
| WO1994016705A3 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
| MX9708385A (es) | Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas. | |
| IT1269545B (it) | Derivati idantoinici |